相关实验视频

Updated: Jan 11, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.4K

瘤回归度预测转化疗法后中期至晚期肝细胞癌的无复发生存率

Haili Zhang1,2, Tongshu Yang3, Luping Huang4

  • 1Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.

Frontiers in immunology
|November 17, 2025
PubMed
概括

在转化疗法后达到TRG1状态显著改善了晚期肝细胞癌 (HCC) 患者的无复发生存率. TRG1的预测因素包括男性性别和TACE与全身疗法结合.

关键词:
转换疗法的转换疗法.肝细胞癌是肝细胞癌.预测 预测 预测 预测没有复发的生存率.瘤回归等级的瘤回归等级.

更多相关视频

The Influence of Liver Resection on Intrahepatic Tumor Growth07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.9K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K